Lipid kinases as therapeutic targets for chronic pain.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 25789432)

Published in Pain on April 01, 2015

Authors

Lipin Loo1, Brittany D Wright, Mark J Zylka

Author Affiliations

1: aDepartment of Cell Biology and Physiology, UNC Neuroscience Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA bNational Center for Advancing Translational Science, Rockville, MD, USA.

Articles cited by this

(truncated to the top 100)

Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem (1994) 14.36

Cellular and molecular mechanisms of pain. Cell (2009) 9.36

Molecular mechanisms of nociception. Nature (2001) 7.75

Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature (2000) 7.66

Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol (2008) 7.43

Visualization of phosphoinositides that bind pleckstrin homology domains: calcium- and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools. J Cell Biol (1998) 6.70

PIP(2) and proteins: interactions, organization, and information flow. Annu Rev Biophys Biomol Struct (2001) 5.66

CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood (2010) 4.69

The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer . J Med Chem (2008) 4.49

ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex. Nat Cell Biol (1999) 4.38

p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron (2002) 4.27

PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med (2005) 3.96

PIP2 is a necessary cofactor for ion channel function: how and why? Annu Rev Biophys (2008) 3.89

A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science (2003) 3.51

Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. Nature (2002) 3.46

Nociceptors--noxious stimulus detectors. Neuron (2007) 3.23

cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron (2002) 3.22

Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res (1994) 3.22

NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J (2005) 3.21

PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol (2012) 3.11

Phosphatidylinositol 4-kinases: old enzymes with emerging functions. Trends Cell Biol (2006) 3.06

A wortmannin-sensitive phosphatidylinositol 4-kinase that regulates hormone-sensitive pools of inositolphospholipids. Proc Natl Acad Sci U S A (1995) 3.02

TRP channels and pain. Annu Rev Cell Dev Biol (2013) 2.94

Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking. Nature (2004) 2.81

Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem (2002) 2.79

Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron (2007) 2.70

Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc Natl Acad Sci U S A (2003) 2.58

Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol (2006) 2.58

Can we conquer pain? Nat Neurosci (2002) 2.56

Dual regulation of TRPV1 by phosphoinositides. J Neurosci (2007) 2.48

Epac mediates a cAMP-to-PKC signaling in inflammatory pain: an isolectin B4(+) neuron-specific mechanism. J Neurosci (2005) 2.47

Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med (2004) 2.46

Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci (2004) 2.41

Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. Proc Natl Acad Sci U S A (2007) 2.41

A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol binding protein and FAPP1. Mol Biol Cell (2005) 2.39

Central mechanisms of pathological pain. Nat Med (2010) 2.37

PIP kinase Igamma is the major PI(4,5)P(2) synthesizing enzyme at the synapse. Neuron (2001) 2.13

Nociceptor sensitization in pain pathogenesis. Nat Med (2010) 2.13

A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep (2008) 2.09

Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate. J Neurosci (2005) 1.97

Phosphatidylinositol [correction] 4,5-bisphosphate signals underlie receptor-specific Gq/11-mediated modulation of N-type Ca2+ channels. J Neurosci (2004) 1.91

Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol (2003) 1.84

Maintenance of hormone-sensitive phosphoinositide pools in the plasma membrane requires phosphatidylinositol 4-kinase IIIalpha. Mol Biol Cell (2007) 1.77

Chromaffin granule-associated phosphatidylinositol 4-kinase activity is required for stimulated secretion. EMBO J (1996) 1.76

Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin. Neurosci Lett (1999) 1.69

Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors. Bioorg Med Chem (2006) 1.62

Cloning of cDNAs encoding two isoforms of 68-kDa type I phosphatidylinositol-4-phosphate 5-kinase. J Biol Chem (1996) 1.59

Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. J Med Chem (2006) 1.54

Phosphatidylinositol 4-kinase is required for endosomal trafficking and degradation of the EGF receptor. J Cell Sci (2006) 1.53

Critical role of PIP5KI{gamma}87 in InsP3-mediated Ca(2+) signaling. J Cell Biol (2004) 1.51

Type Igamma661 phosphatidylinositol phosphate kinase directly interacts with AP2 and regulates endocytosis. J Biol Chem (2006) 1.51

Target-specific PIP(2) signalling: how might it work? J Physiol (2007) 1.45

Modulation of high-voltage activated Ca(2+) channels by membrane phosphatidylinositol 4,5-bisphosphate. Neuron (2010) 1.44

Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia. Eur J Neurosci (2005) 1.44

PtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identity. J Cell Biol (2012) 1.41

Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions. J Neurosci (2008) 1.34

Morphine peripheral analgesia depends on activation of the PI3Kgamma/AKT/nNOS/NO/KATP signaling pathway. Proc Natl Acad Sci U S A (2010) 1.34

Membrane ruffling requires coordination between type Ialpha phosphatidylinositol phosphate kinase and Rac signaling. J Biol Chem (2003) 1.33

Type II phosphatidylinositol 4-kinase beta is a cytosolic and peripheral membrane protein that is recruited to the plasma membrane and activated by Rac-GTP. J Biol Chem (2002) 1.33

Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J Neurosci (2008) 1.30

Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1. Mol Cell Neurosci (2007) 1.28

Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. Proc Natl Acad Sci U S A (2003) 1.28

Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity. PLoS Pathog (2012) 1.23

Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis. J Cell Biol (2009) 1.23

Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats. Exp Neurol (2007) 1.21

Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase. PLoS One (2007) 1.18

Regulation of the actin cytoskeleton by phosphatidylinositol 4-phosphate 5 kinases. Pflugers Arch (2007) 1.14

Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase. Am J Physiol Cell Physiol (2004) 1.12

Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain. EMBO J (2011) 1.07

The beta- and gamma-isoforms of type I PIP5K regulate distinct stages of Ca2+ signaling in mast cells. J Cell Sci (2009) 1.05

Phosphatidylinositol-4-phosphate 5-kinase 1alpha mediates extracellular calcium-induced keratinocyte differentiation. Mol Biol Cell (2009) 1.04

Activation of protein kinase B/Akt signaling pathway contributes to mechanical hypersensitivity induced by capsaicin. Pain (2005) 1.02

Loss of PIP5KIbeta demonstrates that PIP5KI isoform-specific PIP2 synthesis is required for IP3 formation. Proc Natl Acad Sci U S A (2008) 1.02

Loss of phosphatidylinositol 4-kinase 2alpha activity causes late onset degeneration of spinal cord axons. Proc Natl Acad Sci U S A (2009) 1.01

Evaluation of phosphatidylinositol-4-kinase IIIα as a hepatitis C virus drug target. J Virol (2012) 1.01

Phosphatidylinositol-4-phosphate 5-kinases and phosphatidylinositol 4,5-bisphosphate synthesis in the brain. J Biol Chem (2010) 1.01

PIKfyve regulates CaV1.2 degradation and prevents excitotoxic cell death. J Cell Biol (2009) 1.00

Chronic inflammatory pain is associated with increased excitability and hyperpolarization-activated current (Ih) in C- but not Aδ-nociceptors. Pain (2012) 1.00

Diacylglycerol kinase zeta regulates phosphatidylinositol 4-phosphate 5-kinase Ialpha by a novel mechanism. Cell Signal (2004) 1.00

PIKfyve negatively regulates exocytosis in neurosecretory cells. J Biol Chem (2007) 0.99

Differential effects of the phosphatidylinositol 4-kinases, PI4KIIα and PI4KIIIβ, on Akt activation and apoptosis. Cell Death Dis (2010) 0.98

Phosphatidylinositol 4-phosphate 5-kinase alpha (PIPKα) regulates neuronal microtubule depolymerase kinesin, KIF2A and suppresses elongation of axon branches. Proc Natl Acad Sci U S A (2012) 0.98

Phosphoinositides in insulin action on GLUT4 dynamics: not just PtdIns(3,4,5)P3. Am J Physiol Endocrinol Metab (2008) 0.98

Peripheral and central mechanisms of pain generation. Handb Exp Pharmacol (2007) 0.97

Structures of PI4KIIIβ complexes show simultaneous recruitment of Rab11 and its effectors. Science (2014) 0.94

PI3-kinase/Akt pathway-regulated membrane insertion of acid-sensing ion channel 1a underlies BDNF-induced pain hypersensitivity. J Neurosci (2012) 0.94

Conservation of regulatory function in calcium-binding proteins: human frequenin (neuronal calcium sensor-1) associates productively with yeast phosphatidylinositol 4-kinase isoform, Pik1. J Biol Chem (2003) 0.93

The phosphatidylinositol 4-kinases: don't call it a comeback. Subcell Biochem (2012) 0.93

Evaluations of the selectivities of the diacylglycerol kinase inhibitors R59022 and R59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method. Pharmacology (2013) 0.92

Differential mRNA expression and subcellular locations of PI3-kinase isoforms in sympathetic and sensory neurons. J Neurosci Res (1999) 0.91

Modulation of mu opioid receptor desensitization in peripheral sensory neurons by phosphoinositide 3-kinase gamma. Neuroscience (2010) 0.89

Phosphatidylinositol 4, 5 bisphosphate and the actin cytoskeleton. Subcell Biochem (2012) 0.88

The lipid kinase PIP5K1C regulates pain signaling and sensitization. Neuron (2014) 0.87

Discovery and pharmacological characterization of a novel small molecule inhibitor of phosphatidylinositol-5-phosphate 4-kinase, type II, beta. Biochem Biophys Res Commun (2014) 0.87

Neuronal calcium sensor-1: a multifunctional regulator of secretion. Biochem Soc Trans (2003) 0.86

Phosphatidylinositol 4-phosphate 5-kinase α facilitates Toll-like receptor 4-mediated microglial inflammation through regulation of the Toll/interleukin-1 receptor domain-containing adaptor protein (TIRAP) location. J Biol Chem (2013) 0.86

Construction of a global pain systems network highlights phospholipid signaling as a regulator of heat nociception. PLoS Genet (2012) 0.84

Increases in transient receptor potential vanilloid-1 mRNA and protein in primary afferent neurons stimulated by protein kinase C and their possible role in neurogenic inflammation. J Neurosci Res (2009) 0.82

Differential distribution of PI3K isoforms in spinal cord and dorsal root ganglia: potential roles in acute inflammatory pain. Pain (2014) 0.81

Articles by these authors

Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli. Proc Natl Acad Sci U S A (2009) 3.98

Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature (2011) 3.19

Peptidergic CGRPα primary sensory neurons encode heat and itch and tonically suppress sensitivity to cold. Neuron (2013) 1.95

Topoisomerases facilitate transcription of long genes linked to autism. Nature (2013) 1.93

Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Hum Gene Ther (2011) 1.90

Molecular genetic visualization of a rare subset of unmyelinated sensory neurons that may detect gentle touch. Nat Neurosci (2007) 1.78

Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci (2011) 1.72

Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Galpha q/11 pathway. Proc Natl Acad Sci U S A (2002) 1.67

Mrgprd enhances excitability in specific populations of cutaneous murine polymodal nociceptors. J Neurosci (2009) 1.53

Fiber-coupled light-emitting diode for localized photostimulation of neurons expressing channelrhodopsin-2. J Neurosci Methods (2007) 1.38

Mrgprd-expressing polymodal nociceptive neurons innervate most known classes of substantia gelatinosa neurons. J Neurosci (2009) 1.38

AMP is an adenosine A1 receptor agonist. J Biol Chem (2012) 1.36

Ecto-5'-nucleotidase (CD73) inhibits nociception by hydrolyzing AMP to adenosine in nociceptive circuits. J Neurosci (2010) 1.20

CGRPα-expressing sensory neurons respond to stimuli that evoke sensations of pain and itch. PLoS One (2012) 1.20

Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-bisphosphate. J Neurosci (2010) 1.19

PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine. Mol Pain (2011) 1.18

Recombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A(1)-adenosine receptors to mediate antinociception. PLoS One (2009) 1.14

Mechanisms of compartmentalized expression of Mrg class G-protein-coupled sensory receptors. J Neurosci (2008) 1.14

Photochemical activation of TRPA1 channels in neurons and animals. Nat Chem Biol (2013) 1.09

Recombinant ecto-5'-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation. Mol Pain (2010) 1.04

The F-BAR domains from srGAP1, srGAP2 and srGAP3 regulate membrane deformation differently. J Cell Sci (2012) 1.00

Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord. J Neurosci (2013) 0.94

Regulator of G-protein signaling 14 (RGS14) is a selective H-Ras effector. PLoS One (2009) 0.93

Prostatic acid phosphatase is expressed in peptidergic and nonpeptidergic nociceptive neurons of mice and rats. PLoS One (2010) 0.92

PAPupuncture has localized and long-lasting antinociceptive effects in mouse models of acute and chronic pain. Mol Pain (2012) 0.91

A steroid-conjugated contrast agent for magnetic resonance imaging of cell signaling. J Am Chem Soc (2005) 0.90

Needling adenosine receptors for pain relief. Nat Neurosci (2010) 0.88

Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice. J Med Chem (2012) 0.84

A high throughput assay to identify small molecule modulators of prostatic acid phosphatase. Curr Chem Genomics (2009) 0.82

Secretion and N-linked glycosylation are required for prostatic acid phosphatase catalytic and antinociceptive activity. PLoS One (2012) 0.80

Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine. PLoS One (2012) 0.78

Overexpression of diacylglycerol kinase η enhances Gαq-coupled G protein-coupled receptor signaling. Mol Pharmacol (2014) 0.78

Emerging roles for ectonucleotidases in pain-sensing neurons. Neuropsychopharmacology (2011) 0.76

NT5E mutations and arterial calcifications. N Engl J Med (2011) 0.76

Biological constraints limit the use of rapamycin-inducible FKBP12-Inp54p for depleting PIP2 in dorsal root ganglia neurons. J Negat Results Biomed (2013) 0.76

High-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphatase. J Biomol Screen (2012) 0.75